Nanoparticles in Biotechnology, Drug Development and Drug Delivery
The global market for nanoparticles in biotechnology and pharmaceuticals reached nearly $25.0 billion in 2013. This market is expected to reach $29.6 billion in 2014 and $79.8 billion in 2019, with a compound annual growth rate (CAGR) of 22.0% for the period of 2014 to 2019.
This report provides:
An overview of the global market for nanoparticles in biotechnology, drug development, and drug delivery.
Analyses of global market trends, with data from 2012 and 2013, estimates for 2014, and projections of CAGRs through 2019.
A review of existing drug products and potential drugs in the pipelines of the major pharmaceutical players in the market.
A look at how market growth is being driven in emerging geographies stemming from the health awareness of the growing middle class in countries such as India, China, Brazil and Russia.
Analysis of changing market dynamics, emerging players and products, strategies for accessing emerging markets, and analysis of specific disease prevalence.
Profiles of manufacturers of leading products and information on their specific products.